Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
about
Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its managementProteomic and biomarker studies and neurological complications of pediatric sickle cell diseaseBiomarkers and recent advances in the management and therapy of sickle cell diseaseThrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury.Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertensionExpression of regulatory platelet microRNAs in patients with sickle cell diseaseEndothelial activation by platelets from sickle cell anemia patients.Correlation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients.Original insights on thrombospondin-1-related antireceptor strategies in cancer.Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell diseaseRegulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.Thrombospondin-1, free radicals, and the coronary microcirculation: the aging conundrum.Regulation of cellular redox signaling by matricellular proteins in vascular biology, immunology, and cancerMatricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.Prasugrel hydrochloride for the treatment of sickle cell disease.Comment Concerning the Role of CD47 and Signal Regulatory Protein Alpha in Regulating the Clearance of Aged Red Blood Cells.Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.Clinical significance of assessment of thrombospondin and placenta growth factor levels in patients with sickle cell anemia: two centers egyptian studies.Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease.Prominent role of platelets in the formation of circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia.The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1.Stroke with intracranial stenosis is associated with increased platelet activation in sickle cell anemia.Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia.Genetic variation in CD36, HBA, NOS3 and VCAM1 is associated with chronic haemolysis level in sickle cell anaemia: a longitudinal study.Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.Plasma thrombospondin-1 and clinical outcomes in traumatic brain injury.
P2860
Q26864499-66F430BC-DC0A-42F4-94F7-42F9D5EF2321Q27027066-6E58F51B-2153-443D-813E-64C4693E5208Q28082462-0D77A627-0542-4256-9E95-B4F31E06F274Q33660552-ADE4CB2B-3A5C-4CC0-A3A4-F187B46ABC38Q33806253-A44C57FF-B248-4CA0-B80D-633CB0B69957Q34674369-1EBB388F-DCA6-42E4-97F3-D8A0DA4CA457Q35097680-40BB2D67-6581-4401-8F0E-A158229874CAQ35577509-CFECDAD7-5C5E-4B8E-8F94-00A3735572ABQ36221374-95149781-0C49-40D2-B939-938EB511CC93Q36494197-E6C3EAD2-6C41-40FB-9FBF-5E1DA2B3B9B1Q37697630-E70CD7D7-ABA4-426E-9156-44742DAAE69DQ38177946-58C96A0D-CAA4-43EE-AFA6-5E925F6D4632Q38648723-D3161266-523E-4A2D-B04B-5CD52EC5BA04Q38656989-E2704C72-A66D-4D8D-8195-C133EFD22E1EQ39284030-7691D420-D1F1-432B-9FCE-6AD6840288A5Q39340714-0BE3F71C-EA6F-4F41-B648-7FCE46101215Q40203656-725645BF-BBF7-4208-B50D-8993B0B818C4Q41878174-5846D93C-0466-496F-B26A-AA2C9CE6967AQ41905955-47249E53-7071-434F-9935-EF1A209F52EDQ42575618-A2FE4106-E6B8-46C8-B1AA-61735B676725Q42979946-8E951F85-0617-4837-A9FE-B8FBB2CE11EAQ46282340-3FD80370-3611-4F90-B2F8-C848DBCDFE43Q46768117-BC6A073A-010A-4389-86B6-ECAF2CB1B29BQ48107834-1E50A730-2566-4ED1-A1BF-364F4C73B0ACQ48919012-4F1CBAEF-8DC4-4DBC-8ACD-079C6D285EAFQ50019794-D198C8F9-7F8B-4D79-BDEE-16BDF908F0B7Q50230368-8B9144D4-0311-4901-94F7-B68F9FBB7A3FQ51392738-C45468C8-2601-407E-8859-8CEE4ECB8BEDQ52147305-A5E34532-D228-4823-9FEC-5125E4754260
P2860
Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasma thrombospondin-1 is inc ...... py, and lower hemolytic rates.
@en
type
label
Plasma thrombospondin-1 is inc ...... py, and lower hemolytic rates.
@en
prefLabel
Plasma thrombospondin-1 is inc ...... py, and lower hemolytic rates.
@en
P2093
P2860
P356
P1476
Plasma thrombospondin-1 is inc ...... py, and lower hemolytic rates.
@en
P2093
Andrea Cortese Hassett
Enrico M Novelli
Jeffrey S Isenberg
Margaret V Ragni
Mariana E Hildesheim
Mehdi Nouraie
Michael P Meyer
Suchitra Barge
Victor R Gordeuk
Yingze Zhang
P2860
P304
P356
10.1002/AJH.22274
P577
2012-02-08T00:00:00Z